A review of the impact of exercise on treatment related fatigue among patients receiving adjuvant radiotherapy for breast cancer.

Fiona McNally, Paul Shepherd, Terri Flood

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)
157 Downloads (Pure)

Abstract

Purpose
To evaluate the use of exercise in managing fatigue in breast cancer patients undergoing adjuvant radiotherapy. To explore the effectiveness of different exercise practices and explore how optimum management of fatigue might be achieved.

Method
A CINAHL (Cumulative Index to Nursing and Allied Health Literature) database search of literature was undertaken and publications screened for retrieval with 24 qualifying for inclusion in the review.

Results
There is evidence to support various forms of exercise including aerobic, resistance, alternative and combination exercise in the management of fatigue in early stage breast cancer patients undergoing adjuvant radiotherapy. The benefits of exercise for patients with later stage and metastatic disease is less clear and there is a lack of published research related to this category of patient.

Conclusion
Exercise is considered a safe, non-pharmacological intervention for early stage breast cancer patients receiving adjuvant radiotherapy. Further investigation is required into optimum exercise interventions and the effectiveness and viability of supervised and unsupervised models. Patient centred tailored advice and guidance needs to be developed and effectively promoted by therapeutic radiographers in order for patients to fully realise the benefit.
Original languageEnglish
Pages (from-to)295-300
Number of pages6
JournalJournal of Radiotherapy in Practice
Volume18
Issue number3
Early online date14 Jan 2019
DOIs
Publication statusPublished (in print/issue) - 1 Sept 2019

Keywords

  • adjuvant radiotherapy
  • breast cancer
  • chemotherapy
  • exercise
  • fatigue

Fingerprint

Dive into the research topics of 'A review of the impact of exercise on treatment related fatigue among patients receiving adjuvant radiotherapy for breast cancer.'. Together they form a unique fingerprint.

Cite this